4//SEC Filing
Guindo Chirfi 4
Accession 0001127602-23-022015
CIK 0000310158other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:17 PM ET
Size
9.4 KB
Accession
0001127602-23-022015
Insider Transaction Report
Form 4
Guindo Chirfi
Chief Marketing Officer
Transactions
- Exercise/Conversion
Common Stock
2023-08-03$105.70/sh+36,901$3,900,436→ 38,341.684 total - Tax Payment
Common Stock
2023-08-03$105.70/sh−17,989$1,901,437→ 20,352.684 total - Exercise/Conversion
Restricted Stock Unit
2023-08-03−36,901→ 73,804 totalFrom: 2023-08-03Exp: 2025-08-03→ Common Stock (36,901 underlying)
Holdings
- 52.506(indirect: By 401(k))
Common Stock-401(k) Plan
Footnotes (4)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through July 10, 2023 in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001722753
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 4:17 PM ET
- Size
- 9.4 KB